Education
About Us
Working with TipRanks
Follow Us
Merit Medical Systems (MMSI)
NASDAQ:MMSI
Earnings Data
Report Date
Jul 23, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.85Last Year’s EPS
0.92Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 24, 2025
|% Change Since: 2.47%
|Next Earnings Date:Jul 23, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and improved operating margins, with notable performance in the U.S. market and the Cardiovascular segment. However, significant challenges were presented by the impact of tariffs, especially in China, leading to reduced EPS guidance for the year. The company remains optimistic but is navigating a complex macroenvironment.Company Guidance
During the Merit Medical Systems First Quarter 2025 Earnings Conference Call, guidance for the fiscal year 2025 was provided. The company expects total net revenue growth on a GAAP basis to range from 8% to 10% year-over-year, with the Cardiovascular segment projected to grow by 7% to 9% and the Endoscopy segment by 34% to 37%. The guidance includes a foreign currency headwind of approximately $4.9 million. On a constant currency basis, revenue growth is anticipated to be between 8.7% and 10.2%. Non-GAAP EPS is forecasted to be $3.29 to $3.42, adjusted from the initial $3.58 to $3.70, primarily due to tariffs and trade policies, which are expected to increase cost of goods sold by $26.3 million, mostly affecting business in China. Despite these challenges, the company maintains a strong outlook with expected non-GAAP operating margins of 17.6% to 18% and free cash flow of at least $150 million for the year.Revenue Growth Exceeds Expectations
Total revenue for Q1 2025 was $355.4 million, up 9.8% year-over-year on a GAAP basis and 10.9% on a constant currency basis, surpassing growth expectations.
Significant Improvement in Operating Margin
Non-GAAP operating margin increased nearly 230 basis points year-over-year to 19.3%, setting a first-quarter record for the company.
Strong Growth in Cardiovascular and OEM Segments
Cardiovascular segment grew by 9% and OEM products sales increased by 21% in Q1 2025.
Positive U.S. Market Performance
U.S. sales increased 14% on a constant currency basis, exceeding expectations by 170 basis points.
Free Cash Flow Guidance Reaffirmed
The company expects to generate at least $150 million in free cash flow for the fiscal year 2025.
---
MMSI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MMSI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 24, 2025 | $94.67 | $94.61 | -0.06% |
Feb 25, 2025 | $102.03 | $100.45 | -1.55% |
Oct 30, 2024 | $94.90 | $98.66 | +3.96% |
Aug 01, 2024 | $84.12 | $88.74 | +5.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Merit Medical Systems (MMSI) report earnings?
Merit Medical Systems (MMSI) is schdueled to report earning on Jul 23, 2025, TBA Not Confirmed.
What is Merit Medical Systems (MMSI) earnings time?
Merit Medical Systems (MMSI) earnings time is at Jul 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MMSI EPS forecast?
MMSI EPS forecast for the fiscal quarter 2025 (Q2) is 0.85.
---